GLP-1 receptor agonists may improve outcomes in idiopathic intracranial hypertension

For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical outcomes compared with conventional therapies, according to a study published online July 14 in JAMA Neurology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup